Author: Customer Service

ISC Reports Financial Results for the Three Months and Year Ended December 31, 2025

Written by Customer Service on March 20, 2026. Posted in Earnings Releases And Operating Results.

Record annual revenue and adjusted EBITDA of $257.8 million and $103.1 million; annual EPS (diluted) $1.43 Strong high–value registration activity in the Saskatchewan Land Registry, supported by favourable macroeconomic conditions Achieved long-term net leverage target range of 2.0x–2.5x, ahead of scheduleCapitalized terms that are used but not defined in this news release, including section references, have the meanings ascribed to those terms in Management’s Discussion and Analysis for the three months and year ended December 31, 2025. REGINA, Saskatchewan, March 19, 2026 (GLOBE NEWSWIRE) — Information Services Corporation (TSX:ISC) (ISC or the Company) today reported on the Company’s financial results for the quarter and year ended December 31, 2025. Commenting on ISC’s results, Shawn Peters, President and CEO...

Grupo Aeroportuario del Pacifico Announces Refinancing of Bank Loan for USD$95.5 Million

Written by Customer Service on March 20, 2026. Posted in Public Companies.

GUADALAJARA, Mexico, March 19, 2026 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (the “Company” or “GAP”) announced that today it refinanced a bank loan for USD$95.5 million with BBVA México, S.A., which was due on this same date, by entering into a new financing agreement with the same institution. The new loan has a six-month term, with the option to extend for an additional six months, with interest payable monthly at a variable rate equivalent to SOFR plus 40 basis points. It also includes a structuring fee of 10 basis points and, if the extension option is exercised, an additional fee of 10 basis points. The principal will be paid at maturity. Company Description Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (GAP) operates 12 airports throughout Mexico’s Pacific region, including...

Maxim Power Corp. Announces 2025 Fourth Quarter Financial and Operating Results

Written by Customer Service on March 20, 2026. Posted in Earnings Releases And Operating Results.

CALGARY, Alberta, March 19, 2026 (GLOBE NEWSWIRE) — Maxim Power Corp. (“MAXIM” or the “Corporation”) (TSX: MXG) announced today the release of financial and operating results for the fourth quarter ended December 31, 2025. The audited consolidated financial statements, accompanying notes and Management’s Discussion and Analysis (“MD&A”) will be available on SEDAR+ and on MAXIM’s website on March 19, 2026. All figures reported herein are Canadian dollars unless otherwise stated. FINANCIAL HIGHLIGHTS Three Months EndedDecember 31, Twelve Months EndedDecember 31,($ in thousands except per share amounts) 2025 2024 2025 2024 Revenue 17,966 24,048 86,873 101,482 Net income (loss) 2,422 (341 ) 16,694 21,946 Earnings (loss) per share – basic 0.04 (0.01 ) 0.26 0.42 Earnings...

BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026

Written by Customer Service on March 19, 2026. Posted in Public Companies.

SUNNYVALE, Calif., March 19, 2026 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for the year ended December 31, 2025 by conference call on Tuesday, March 24, 2026 at 4:30 PM EDT. Following management’s formal remarks, there will be a question-and-answer session. Participants can register for the conference by navigating to https://dpregister.com/sreg/10207584/1039b7a7360. Please note that registered participants will receive their dial-in number upon registration. For those who have not registered, to listen to the call by phone, interested parties within the U.S. should call 1-833-316-0559 and international callers should call 1-412-317-5730....

Condor Announces 2025 Year-End Results

Written by Customer Service on March 19, 2026. Posted in Earnings Releases And Operating Results.

CALGARY, Alberta, March 19, 2026 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX:CDR), a Canadian based, internationally focused energy transition company focused on Central Asia is pleased to announce the release of its audited consolidated financial statements for the years ended December 31, 2025 and 2024 (the Financial Statements”), together with the related management’s discussion and analysis. These documents will be made available under Condor’s profile on SEDAR+ at www.sedarplus.ca and on the Condor website at www.condorenergies.ca. Readers are invited to review the latest corporate presentation available on the Condor website. All financial amounts in this news release are presented in Canadian dollars, unless otherwise stated. HIGHLIGHTSProduction in Uzbekistan for the fourth quarter of 2025...

CORRECTION – Hammond Power Solutions Reports Fourth Quarter 2025 Financial Results

Written by Customer Service on March 19, 2026. Posted in Earnings Releases And Operating Results.

(Dollar amounts are in thousands, in Canadian currency unless otherwise specified) GUELPH, Ontario, March 19, 2026 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Hammond Power Solutions Inc. (TSX: HPS.A), please note that the Quarterly adjusted EBITDA should be 15.2% of sales, not 13.5% as previously stated. The corrected release follows: Hammond Power Solutions Inc. (“HPS” or the “Company”) (TSX: HPS.A) a leading manufacturer of dry-type transformers, power quality products and related magnetics, today announced its financial results for the fourth quarter 2025. QUARTERLY HIGHLIGHTS:Record annual sales of $898 million, a 13.9% increase versus 2024; Quarterly adjusted EBITDA of $38.7 million, or 15.2% of sales; Record annual adjusted EBITDA of $133.3 million, or 14.8% of sales; Quarterly adjusted...

Cellectis Reports Full Year 2025 Financial Results and Provides a Business Update

Written by Customer Service on March 19, 2026. Posted in Earnings Releases And Operating Results.

Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) ongoingPhase 1: 83% ORR at RP2D and 100% ORR in the target Phase 2 population In target Phase 2 population: 100% of patients became eligible to transplant Pivotal Phase 2 first interim analysis expected in Q4 2026 BLA submission anticipated in 2028Phase 1 with eti-cel in r/r NHL (NATHALI-01 trial) ongoingBest-in-class dual allogeneic CAR-T cell product targeting CD20 & CD22 At current dose level, 88% ORR; 63% CR rate after 2+ prior lines of therapy 93% of subjects had prior CD19 CAR-T Low-dose IL-2 cohort to be included in; Full Phase 1 dataset expected in Q4 2026PartnershipsServier (through Allogene): Pivotal randomized Phase 2 ALPHA3 trial with cema-cel in 1L consolidation in LBCL: interim futility analysis evaluating MRD clearance and early safety...

Diversified Royalty Corp. Announces Fourth Quarter and Year End 2025 Results

Written by Customer Service on March 19, 2026. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, March 19, 2026 (GLOBE NEWSWIRE) — Diversified Royalty Corp. (TSX: DIV, DIV.DB.A and DIV.DB.B) (the “Corporation” or “DIV”) is pleased to announce its financial results for the three months (“Q4 2025”) and year ended December 31, 2025. HighlightsThe weighted average organic royalty growth1 of DIV’s diversified royalty portfolio was 3.0% in Q4 2025 and 4.1% for the year ended December 31, 2025, compared to 5.2% for the three months ended December 31, 2024 (“Q4 2024”) and 4.6% for the year ended December 31, 2024. The weighted average organic royalty growth1 on a constant currency basis was 3.0% in Q4 2025 and 3.8% for the year ended December 31, 2025, compared to 4.8% for Q4 2024 and 4.3% for the year ended December 31, 2024. Revenue was $19.1 million in Q4 2025 and $70.8 million for the year ended...

Pacific Health Care Organization, Inc. Reports its 2025 Year-End Financial Results

Written by Customer Service on March 19, 2026. Posted in Public Companies.

Irvine, CA, March 19, 2026 (GLOBE NEWSWIRE) — Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) filed Tuesday with the Securities and Exchange Commission (the “SEC”) its annual report on Form 10-K announcing its financial results for the fiscal year ended December 31, 2025. Results The Company reported total revenues of $6,715,175 for the year ended December 31, 2025 (“fiscal year 2025”), compared to $6,065,390 for the year ended December 31, 2024 (“fiscal year 2024”). The Company reported income from operations of $1,001,038 for fiscal year 2025, compared to income from operations of $852,623 for fiscal year 2024. The Company realized net income of $1,387,647 or $0.11 per weighted average share outstanding, basic and diluted, for fiscal year 2025, compared to net income of $883,584 or $0.07 per weighted...

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity

Written by Customer Service on March 19, 2026. Posted in Public Companies.

David Meeker QuoteDavid Meeker QuoteDr. Shoemaker quoteDr. Shoemaker quoteIMCIVREE packagingIMCIVREE packaging with vialIMCIVREE 3D RenderIMCIVREE 3D Render— First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or dysfunction – — Indicated to reduce excess body weight and maintain reduction long term in adults and pediatric patients aged 4 years and older with acquired hypothalamic obesity — — Approval based on -18.4% placebo-adjusted BMI reduction achieved by setmelanotide in global Phase 3 TRANSCEND trial [N=142] — — Company to host conference call today at 7:00 p.m. ET — BOSTON, March 19, 2026 (GLOBE NEWSWIRE) — Rhythm...

Author: Customer Service

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals